Monte Rosa Therapeutics (GLUE) Prepaid Assets (2020 - 2026)

Monte Rosa Therapeutics' (GLUE) quarterly Prepaid Assets came in at $6.7 million in Q1 2026, up 40.02% year-on-year from $4.8 million in Q1 2025, and up 49.92% quarter-over-quarter from $4.5 million in Q4 2025.

Monte Rosa Therapeutics (GLUE) Prepaid Assets (2020 - 2026) Analysis & Trends

Monte Rosa Therapeutics' Prepaid Assets history runs 7 years deep, the most recent figure standing at $6.7 million for Q1 2026.

  • On a quarterly basis, Prepaid Assets rose 40.02% year-over-year to $6.7 million in Q1 2026; TTM through Mar 2026 was $6.7 million, a 40.02% increase from a year earlier, with the FY2025 full-year figure at $4.5 million, down 12.45% from the prior year.
  • Prepaid Assets improved to $6.7 million in Q1 2026 per GLUE's latest filing, from $4.5 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $8.4 million in Q3 2024 and bottomed at $2.9 million in Q2 2022.
  • The 5-year median for Prepaid Assets is $4.8 million (2025), against an average of $5.0 million.
  • Across the five-year window, Prepaid Assets jumped 135.96% in 2022 and tumbled 33.61% in 2025, its largest moves.
  • Year by year, Prepaid Assets stood at $4.4 million in 2022, then fell by 25.88% to $3.3 million in 2023, then jumped by 55.37% to $5.1 million in 2024, then slipped by 12.45% to $4.5 million in 2025, then jumped by 49.92% to $6.7 million in 2026.
  • Per Business Quant, the three latest GLUE Prepaid Assets figures stand at $6.7 million (Q1 2026), $4.5 million (Q4 2025), and $5.6 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Monte Rosa Therapeutics 2.30 Bn 1.62 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 6.72 Mn
Dec 31, 2025 4.48 Mn
Sep 30, 2025 5.59 Mn
Jun 30, 2025 6.50 Mn
Mar 31, 2025 4.80 Mn
Dec 31, 2024 5.12 Mn
Sep 30, 2024 8.43 Mn
Jun 30, 2024 5.85 Mn
Mar 31, 2024 5.54 Mn
Dec 31, 2023 3.29 Mn
Sep 30, 2023 4.14 Mn
Jun 30, 2023 3.88 Mn
Mar 31, 2023 5.69 Mn
Dec 31, 2022 4.44 Mn
Sep 30, 2022 4.57 Mn
Jun 30, 2022 2.90 Mn
Mar 31, 2022 3.20 Mn
Dec 31, 2021 2.60 Mn
Sep 30, 2021 3.49 Mn
Jun 30, 2021 1.23 Mn